RQMIS Joins M-Corps to Enhance Support for Medical Product Development
Amesbury, MA – July 17, 2024 – RQMIS, Inc., a premier consulting firm specializing in regulatory, clinical, quality, and cybersecurity services, is proud to announce its membership in M-Corps, a distinguished component of the Medical Technology Enterprise Consortium (MTEC). This collaboration marks a significant step in RQMIS’s mission to support and advance medical product development by providing expert guidance to MTEC members.
M-Corps is an exclusive network of trusted subject matter experts and service providers dedicated to assisting MTEC members with the complex business, technical, and regulatory challenges inherent in the medical product development process. As a member of M-Corps, RQMIS will leverage its extensive experience and industry knowledge to deliver tailored consulting services that facilitate innovation and compliance.
About RQMIS
RQMIS offers a comprehensive suite of services to the global medical device, pharmaceutical, nutraceutical, and cosmetic industries, including:
- Regulatory Consulting: Expertise in regulatory submissions, strategic planning, and compliance with international regulations.
- Clinical Consulting: Design and management of clinical trials, development of clinical evaluation reports, and post-market surveillance.
- Quality Management: Implementation and optimization of Quality Management Systems, audit preparation, and CAPA plans.
- Cybersecurity: Risk assessments, implementation of cybersecurity measures, and compliance with data protection regulations.
Commitment to Excellence
“Our membership in M-Corps is a testament to RQMIS’s dedication to supporting the development of innovative medical products,” said Barry Sands, President and Founder of RQMIS. “We are honored to join this esteemed group of experts and look forward to collaborating with MTEC members to navigate the intricacies of regulatory compliance and product development.”
About MTEC and M-Corps
The Medical Technology Enterprise Consortium (MTEC) is a non-profit organization that aims to accelerate the development of medical technologies to improve healthcare outcomes for military personnel and civilians. M-Corps, a component of MTEC, comprises select trusted experts and service providers poised to assist MTEC members in navigating the business, technical, and regulatory intricacies of medical product development.
Looking Forward
By joining M-Corps, RQMIS is poised to provide unparalleled support to MTEC members, helping them achieve their goals of bringing safe, effective, and innovative medical products to market. This partnership underscores RQMIS’s commitment to excellence and its ongoing effort to drive advancements in the medical product industry.
For more information about RQMIS and its services, please visit https://rqmis.com/ or contact fmanning@rqmis.com.
Contact:
Frank Manning
Business Development Manager
RQMIS, Inc.
978-358-7307
frankmanning@rqmis.com
https://rqmis.com
About RQMIS, Inc.:
RQMIS, Inc. is a leading consulting firm that provides regulatory, clinical, quality, and cybersecurity services to the global medical device, pharmaceutical, nutraceutical, and cosmetic industries. With a commitment to excellence and a deep understanding of the regulatory landscape, RQMIS helps companies navigate complex challenges and achieve compliance, ensuring their products meet the highest standards of safety and efficacy.
About MTEC:
The Medical Technology Enterprise Consortium (MTEC) is a 501(c)(3) biomedical technology consortium collaborating under an Other Transaction Agreement (OTA) with the U.S. Army Medical Research and Development Command (USAMRDC). MTEC’s goal is to accelerate the development of medical solutions that prevent and treat injuries and restore health to U.S. service members and civilians.
RQMIS and Twin Tech Labs Announce Joint Partnership
Boston, June 26, 2023
RQMIS, Inc. and Twin Tech Labs are pleased to announce a new partnership to bring cybersecurity testing and monitoring to the ever-expanding market of software-based medical products and their associated network and cloud-based platforms. FDA’s recent publications and guidance regarding premarket and post market requirements for cybersecurity testing and monitoring of medical devices have significantly expanded the regulatory threshold for a pathway to market. Twin Tech Labs brings to the table decades of experience in IoT, machine learning, and cybersecurity, including leveraging best-in-class open-source components and frameworks to secure digital assets.
Positive Customer Impact
RQMIS clients have already benefited from the ongoing guidance and penetration testing by Twin Tech Labs. One of our clients has developed a medical device designed to help manage emergency triage by determining the likelihood of internal hemorrhage after connecting wirelessly to patient monitoring equipment. Their device was subjected to cybersecurity penetration testing which demonstrated the secure environment created by the device. Another RQMIS client is designing a smartphone-based defibrillator with interfaces to the emergency phone system and cloud-based communications. Twin Tech Labs is ensuring the safe and secure operation of the client’s product and confirming the device’s confidentiality, HIPAA, and GDPR compliance.
About RQMIS
Founded in 1996, RQMIS, Inc. is the worldwide leader in therapeutically focused comprehensive regulatory, quality, and clinical consulting to the global medical device, pharmaceutical, nutraceutical and cosmetic industries. The company offers a wide range of products and services designed to execute the most efficient and cost-effective commercialization pathway for our clients worldwide.
Note: The names of actual companies and products mentioned herein may be the trademarks of their respective owners.
For more information and press only:
PR Contact Name: Frank Manning
Phone number: 978-834-5093
Email: frankmanning@rqmis.com
For more information on Twin Tech Labs:
M2D2 Cycle 5 Pitch-Off!!!
These events truly set the stage for early-stage entrepreneurs to connect with investors, strategics, and all the ecosystem supporters who will help them on their journey.
On Tuesday, April 4, we will be back at it. 10 startups from the current #IMPACT Cohort. New stories to be told, new relationships to be created. Kyle Kruse 🚀 back on MC duties bringing the buzz. And you the audience, get to pick one of the prize winners, with our interactive voting platform!
Relive the magic from our last Cohort Pitch-off in the video and check out the people and startups involved in Cycle 5 below. We hope you can join us for another energizing evening of startup pitching!! (link to register in the comments)
Kicking off with a keynote from Rajit Kamal - Finding the exit: what strategics are looking for from startups.
Startups:
Stan Sansone from 911 Medical Devices
Diana Hall from ActivArmor
Nazgol Tavabi from BonePixel
Jeffrey Ruberti from BrilliantStrings Therapeutics
SARAH DILLINGHAM from Grace & Able
Ben Jackson from JAM.ai
Marcel M. from KAT Innovation
Benjamin Holmes from Nanochon
Rabeeh M. from OrthoKinetic Track
Jason Winder from Sonogen Medical Inc.
Thank you to our judges and prize sponsors!! Mira Sahney, Ibraheem Badejo, Ph.D., Lisa Donnelly, TOM GAMACHE, Ilsa Webeck, & peter stebbins
Upteaming, Life Science Nation, RedCrow, PQE Group, Agile Search Inc. & Product
The Medtech Conference, October 9-11, 2023, Anaheim, CA
The MedTech Conference brings the top executives and innovators from across the world (and the industry) together to explore critical topics, share visions for the future — and build them, together.
RQMIS will be attending as an exhibitor. Our goal is to meet with existing and prospective clients to give them more insight into our unique approach to bringing their products to market.
MEDICA 2023 Conference - World Forum for Medicine, November 13, 2023 - November 16, 2023, Dusseldorf, Germany
RQMIS is excited to be participating in MEDICA 2023 - the world's leading international medical trade fair. The conference will be held in Dusseldorf, Germany, and will showcase over 5,000 exhibitors from 70 countries.
This year RQMIS has been invited to the Corporate Executive Office in the US Pavilion, organized and supported by the U.S. Department of Commerce. Our goal is to meet with existing and prospective clients to give them more insight into our unique approach to bringing their products to market. Come visit us! Click to learn more